FDA approves new allergic asthma treatment Xolair
The FDA approved the bioengineered drug Xolair for serious allergic asthma, offering a novel mechanism that blocks reactions before symptoms appear. It costs 5000 to 10000 dollars yearly and may help about 15 percent of patients avoid attacks, with safety concerns including rare life threatening reactions and a slight cancer signal.
MENTIONED IN THIS ARTICLE
Washington
Food and Drug Administration
FDA
Joe Wagner
Stockholm
N.J
Catholic bishops say reforms still on track
In St Louis the US bishops reaffirm their commitment to clergy abuse reforms after a turbulent week. Bishop Wilton Gregory and Archbishop Harry Flynn stressed the plan remains in place, while critics from the National Review Board and SNAP pressed for accountability and change.
MENTIONED IN THIS ARTICLE
ST. Louis
America
Wilton Gregory
Belleville
Conference of Catholic Bishops
Harry Flynn
St. Paul
Minneapolis
Flynn
National Review Board
SNAP
National Assembly
Mark Serrano
Virginia
Woman can sue over religious sign in front yard dispute
Sybil Peachlum wins revival of her lawsuit as the 3rd US Circuit Court of Appeals says her claim is ripe. The case centers on a 3.5 by 5 foot neon peach holding a paper with Jesus is Alive, which York City barred as a sign violating zoning rules.
MENTIONED IN THIS ARTICLE
Philadelphia
Sybil Peachlum
York City
Jesus
Peachlum
Circuit Court of Appeals
Erik Stanley
Liberty Counsel
Stanley
Also Mentioned on This Page
Bob Lanier
University of North Texas Health Science Center
Genentech Inc
Tanox Inc
Novartis Pharmaceuticals
East Jackson Street
York
City Hall
PCS
Tor
Sprint
Sprintpcs.com
Poe
Samsung
Calfinar Reamin
Fox
Sorin
Polyere
The
Eee
Odessa Santa Fe
East 42Nd St
Midland Midland Plaza
Mervyn
Florida
Wwe
Carwight
Ance Montana
Marilyn
Hollander
Marilyn Sanchez
Las Vegas
Leona Walters
Aurelio Melcher
Matt Scott
Roger Holen
Hiollander
West Odessa Midland
East Odessa
Susan Wiggins
Santos Maldonado
Rob Sadier
VAX
Chad Hetrick